Black Diamond Therapeutics Inc (BDTX)
2.54
+0.11
(+4.53%)
USD |
NASDAQ |
Nov 22, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
Black Diamond Therapeutics Cash from Investing (Quarterly): 2.193M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.193M |
| June 30, 2024 | 0.74M |
| March 31, 2024 | -13.73M |
| December 31, 2023 | 12.25M |
| September 30, 2023 | -37.88M |
| June 30, 2023 | 17.18M |
| March 31, 2023 | 24.81M |
| December 31, 2022 | 2.322M |
| September 30, 2022 | 14.51M |
| June 30, 2022 | 19.81M |
| March 31, 2022 | 16.73M |
| December 31, 2021 | 43.24M |
| Date | Value |
|---|---|
| September 30, 2021 | 35.70M |
| June 30, 2021 | 48.20M |
| March 31, 2021 | 3.474M |
| December 31, 2020 | -6.648M |
| September 30, 2020 | 4.597M |
| June 30, 2020 | -279.64M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.002M |
| September 30, 2019 | -0.011M |
| June 30, 2019 | 0.002M |
| March 31, 2019 | -0.01M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-279.64M
Minimum
Jun 2020
48.20M
Maximum
Jun 2021
-4.608M
Average
4.036M
Median
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | 12.06M |
| IDEAYA Biosciences Inc | -20.04M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.713M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.32M |
| Cash from Financing (Quarterly) | -0.252M |
| Free Cash Flow | -61.20M |
| Free Cash Flow Per Share (Quarterly) | -0.2004 |
| Free Cash Flow Yield | -44.79% |